Real-time enrollment status for this breast cancer, metastatic clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:40 AM UTC
| NCT Number | NCT07007559 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer, Metastatic |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 21 sites in the US |
| Sponsor | ALX Oncology Inc. |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 13, 2026: Clinical trial NCT07007559 is currently recruiting participants. This clinical trial study for breast cancer, metastatic is actively seeking new participants at 21 locations across the United States. The study is sponsored by ALX Oncology Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07007559 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07007559 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.